Conditions

Stem Cell Therapy for Neuropathy: What the Research Says

A cautious look at what's being investigated for peripheral neuropathy and nerve-related pain — why the evidence is early, and the questions worth asking before any treatment.

Conditions  ·  By the Regenerative Treatment Guide Editorial Team  ·  Medical review by our Medical Advisory Board (forming)  ·  Updated June 10, 2026  ·  6 min read

Neuropathy — burning, tingling, numbness, or nerve pain, often in the hands and feet — can be relentless, and conventional treatment doesn't always bring enough relief. That gap leads many people to search for alternatives, including stem cell therapy. We want to be especially direct on this topic: the evidence for regenerative medicine in neuropathy is early and limited, and no provider can honestly promise a cure. This guide explains what neuropathy is, what's actually being investigated, who might explore it, and the questions worth asking — written to help you make an informed, eyes-open decision rather than to sell you on a treatment.

Understanding neuropathy

Neuropathy refers to damage or dysfunction of the peripheral nerves — the nerves outside the brain and spinal cord. Peripheral neuropathy commonly causes numbness, tingling, burning pain, or weakness, frequently starting in the feet or hands. Importantly, neuropathy has many different underlying causes: diabetes is among the most common, but it can also stem from injury, chemotherapy, autoimmune conditions, infections, vitamin deficiencies, and more. Sometimes no cause is found (idiopathic neuropathy).

Because the causes are so varied, the single most important step is a proper diagnosis — ideally from a neurologist — to identify what's driving the nerve damage. Treating that underlying cause (for example, tightly managing blood sugar in diabetic neuropathy) is central to care, and it shapes whether any other option is even reasonable to consider.

What is being investigated with stem cells?

Regenerative medicine for nerve conditions is a real area of scientific interest. Researchers are studying whether mesenchymal stem cells (MSCs) and their signaling factors might influence inflammation and the local environment around damaged nerves in certain types of neuropathy. Studies are indexed on PubMed, and some trials are registered on ClinicalTrials.gov.

But this is genuinely earlier-stage than the joint research. Most regenerative medicine evidence and clinical use has centered on orthopedic conditions like the knee; nerve-related applications are studied less, in smaller and more varied trials. To learn how stem cells are thought to work more broadly, see our complete guide to stem cell research.

What the evidence does — and doesn't — support

The honest summary: regenerative approaches for neuropathy are investigational, the evidence is limited, and candidacy varies widely. Some early research is encouraging for certain types of neuropathy, but it is far from the level of evidence needed to consider this a proven treatment. Anyone telling you stem cells will reliably reverse nerve damage or cure neuropathy is going well beyond what the science supports.

This is exactly the kind of area where the FDA has cautioned consumers about unapproved stem cell products and clinics making unsupported claims. For the regulatory picture, see our guide to whether stem cell therapy is FDA approved and safe.

Want help finding a credible, board-certified provider?

Take a 2-minute assessment and we'll match you with a verified clinic that frames treatment honestly. Free, no obligation.

Take the Free Assessment

Who might explore it — and who shouldn't rush in

Only a licensed physician can determine whether any approach is appropriate, and for neuropathy that conversation should start with a neurologist. People who sometimes explore investigational regenerative options include those with certain types of peripheral neuropathy whose symptoms haven't responded to standard care — but only after the underlying cause has been identified and addressed.

Be cautious if you encounter clinics that: promise to "cure" neuropathy, skip a proper neurological diagnosis, push large upfront payments, or are vague about cell sourcing and the investigational nature of the treatment. Certain conditions — active cancer, active infection, or certain blood disorders — may also make someone not a candidate for any regenerative procedure.

What does it cost?

When offered, regenerative treatments generally fall in the U.S. range of roughly $3,000 to $10,000 per session, and because these uses are investigational, insurance does not cover them. Given the limited evidence for neuropathy specifically, the cost-versus-benefit question deserves extra scrutiny here. For a full breakdown, see our guide on how much stem cell therapy costs.

Questions to ask a provider

  • Has a neurologist diagnosed the underlying cause of my neuropathy?
  • Is this treatment FDA-approved or investigational for my specific type of neuropathy?
  • What does the evidence actually show for my situation — honestly?
  • What cell source do you use, and how is it processed?
  • What are the realistic expected outcomes, the risks, and the total cost?

Frequently asked questions

No. The FDA has not approved stem cell or other regenerative products to treat neuropathy. The only approved stem cell products are blood-forming cells derived from umbilical cord blood, approved for blood-production disorders. Any stem cell treatment offered for neuropathy or nerve pain should be considered investigational, and the FDA has cautioned consumers about unapproved stem cell products.
No reputable provider can promise a cure. Certain types of peripheral neuropathy are being investigated in early-stage research, but the evidence is limited and candidacy varies widely. Be especially cautious of any clinic marketing stem cells as a guaranteed cure for neuropathy.
Research has explored regenerative approaches for some forms of peripheral neuropathy and nerve-related pain, including certain diabetic and idiopathic cases. However, neuropathy has many different causes, and what is being investigated for one type may not apply to another. A neurologist's diagnosis of the underlying cause is an essential first step.
Most regenerative medicine research and clinical use has centered on orthopedic and joint conditions. Nerve-related applications are earlier-stage, with smaller and more varied studies, so the evidence base is thinner. That makes a thorough physician evaluation and realistic expectations especially important here.
See a physician — ideally a neurologist — to identify the underlying cause, since treating that cause (for example, managing blood sugar in diabetic neuropathy) is central to care. Only after that evaluation should any investigational regenerative option be considered, and only with a qualified provider who frames it honestly.

Looking for an honest, qualified opinion?

Take a 2-minute assessment and we'll match you with a verified, board-certified clinic near you.

Take the Free Assessment

Related reading

This article is for educational purposes only and is not medical advice. The use of stem cell therapy for neuropathy is investigational and not FDA-approved, the evidence is limited, and individual results vary and are not guaranteed. Always consult a qualified healthcare provider — ideally a neurologist — about your specific situation.